Authors:
Clark, JI
Kancharla, K
Qamar, R
Fisher, S
Hantel, A
Panganiban, J
Millbrandt, L
Albain, KS
Citation: Ji. Clark et al., Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 271-277
Authors:
Unger, JM
Flaherty, LE
Liu, PY
Albain, KS
Sondak, VK
Citation: Jm. Unger et al., Gender and other survival predictors in patients with metastatic melanoma on southwest oncology group trials, CANCER, 91(6), 2001, pp. 1148-1155
Authors:
Gotay, CC
Moinpour, CM
Moody-Thomas, S
Gritz, ER
Albain, KS
DeAntoni, E
Hansen, L
Ganz, PA
Citation: Cc. Gotay et al., Behavioral science research in the cooperative group setting: The Southwest Oncology Group experience, J NAT CANC, 92(17), 2000, pp. 1381-1387
Authors:
Hillner, BE
Ingle, JN
Berenson, JR
Janjan, NA
Albain, KS
Lipton, A
Yee, G
Biermann, JS
Chlebowski, RT
Pfister, DG
Citation: Be. Hillner et al., American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer, J CL ONCOL, 18(6), 2000, pp. 1378-1391
Citation: Ks. Albain, Sex-associated differences in survival of patients undergoing resection for lung cancer - Invited commentary, ANN THORAC, 69(1), 2000, pp. 249-250
Citation: Ji. Clark et Ks. Albain, Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma, CANC TREAT, 2000, pp. 149-170
Authors:
Hutchins, LF
Unger, JM
Crowley, JJ
Coltman, CA
Albain, KS
Citation: Lf. Hutchins et al., Underrepresentation of patients 65 years of age or older in cancer-treatment trials., N ENG J MED, 341(27), 1999, pp. 2061-2067